Variant NM_000492.4:c.1209G>C
Name | NM_000492.4:c.1209G>C |
Protein name | NP_000483.3:p.(Glu403Asp) |
Genomic name (hg19) | chr7:g.117182162G>C UCSC |
#Exon/intron | exon 9 |
Legacy Name | E403D |
Class | disease-causing |
Subclass | CF-causing |
WT sequence | AGAATGTAACAGCCTTCTGGGAGGA G GTCAGAATTTTTAAAAAATTGTTTG |
Mutant sequence | AGAATGTAACAGCCTTCTGGGAGGA C GTCAGAATTTTTAAAAAATTGTTTG |
Not found | dbSNP rs397508177 |
Reference | PMID | Splicing | mRNA level | Maturation | Localization | Channel fonction (Cl-) | Bicarbonate |
Bergougnoux et al, 2022 | 36567205 | ✓ | ✓ | ✓ | ✓ | ✓ |
« ✓ » indicates the type of analysis performed and not the results
Modulator | FDA approval | EMA approval | in vitro / ex vivo data | clinical data |
IVA | no | no | no | no |
TEZ-IVA | yes | no | yes | no |
ELX-TEZ-IVA | yes | no | yes | no |
clinical and functional data are provided by Vertex
No patient found in CFTR-NGS catalogue |
TOTAL NUMBER OF PATIENTS | 4 |
---|---|
CF | 3 |
Pending (NBS) | 1 |
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
Phenotype | Patient ID | Variant status | Additional variants |
---|---|---|---|
CF | 2333 | heterozygote | CF-causing- Undef |
CF | 2478 | heterozygote | CF-causing- Undef |
CF | 2950 | heterozygote | CF-causing - Trans |
Pending (NBS) | 4644 | heterozygote | varying clinical consequence- Undef |
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
CFTR variants are clustered into five groups: |
|